About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Maryland | 900 Studies

Clinical Trials Breast CancerMaryland

Breast Cancer Clinical Trials in Maryland

Find 900 clinical trials for breast cancer near Maryland. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Maryland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 261-280 of 900 trials

Active not recruitingStudy of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)The purpose of this study is to assess the efficacy and safety of pembrolizumab (MK-3475) versus placebo in combination with neoadjuvant (pre-surgery) chemotherapy and adjuvant…NCT03725059·Daphne, Alabama and 243 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

UnknownLetrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast CancerRATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer by lowering the amount of estrogen the body makes.NCT00382070·Anniston, Alabama and 805 others

RecruitingConfirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast TumorsPrior to this confirmatory pivotal study, the multicenter Br-002 feasibility study was completed.NCT03463954·Duarte, California and 12 others

CompletedIsolation and Characterization of Mammary Stem CellsBackground: * Cancer stem cells in breast cancer have been identified as a small population of tumor cells whose self-renewal mechanism is highly deregulated.NCT00340392·Bethesda, Maryland

CompletedComparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00024102·Birmingham, Alabama and 333 others

CompletedInvolving Family to Improve Communication in Breast Cancer CareThis study evaluates a multi-component communication intervention in the outpatient setting to strengthen communication among patients being actively treated for breast cancer and…NCT03283553·Baltimore, Maryland and 1 other

CompletedHigh-Risk Breast Duct EpitheliumBackground: * Breast cancer is the most common malignancy in women, occurring in over 230,000 women annually in the United States.NCT00028340·Bethesda, Maryland

CompletedIxabepilone in Treating Patients With Locally Advanced or Metastatic Breast CancerRATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00045097·Bethesda, Maryland and 3 others

Active not recruitingRandomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast CancerThe primary objective of this study is to demonstrate that the combination of palbociclib with anti-HER2 therapy plus endocrine therapy is superior to anti-HER2-based therapy plus…NCT02947685·San Francisco, California and 107 others

CompletedAutologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive ChemotherapyThe ability of chemotherapy to cure cancer, including breast cancer, has been limited by drug resistant residual tumor cells remaining after chemotherapy that generally result in…NCT00001440·Bethesda, Maryland

CompletedA Study to Assess the Effect of AZD5462 on the Pharmacokinetics of Midazolam, Rosuvastatin and DigoxinThis study will assess the effect of multiple doses of AZD5462 on the PK of oral midazolam (CYP3A4 probe), rosuvastatin (OATP1B1/3, BCRP probe), and digoxin (P-gp probe) in…NCT05395117·Brooklyn, Maryland

CompletedA Study of LY2523355 in Participants With Breast CancerThe purpose of the study is to evaluate the anti-tumor activity of LY2523355 relative to ixabepilone for the treatment of metastatic or locally recurrent breast cancer using…NCT01416389·Fort Myers, Florida and 11 others

TerminatedGemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid TumorsRATIONALE: Drugs used in chemotherapy, such as gemcitabine, use different ways to stop tumor cells from dividing so they stop growing or die.NCT00049608·Bethesda, Maryland

CompletedPreoperative Accelerated Partial Breast Irradiation (APBI) for Women With Stage I and Select IIA Breast CancerThe purpose of this study is to examine the feasibility to deliver PBI before the lumpectomy is performed.NCT01014715·Baltimore, Maryland and 2 others

CompletedThe Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast CancerThe purpose of this study is to compare the efficacy of Faslodex (fulvestrant) to Aromasin (exemestane) in hormone receptor positive postmenopausal women with advanced breast…NCT00065325·Birmingham, Alabama and 116 others

UnknownStudy of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 SignalingThis is a prospective, single arm, open label, multicenter interventional study designed to evaluate the efficacy of neoadjuvant chemotherapy with anti-HER2 antibodies in patients…NCT03412643·Colton, California and 42 others

Active not recruitingS1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerRATIONALE: Estrogen can cause the growth of breast cancer cells.NCT01674140·Birmingham, Alabama and 1457 others

Active not recruitingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersTTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase 2 dose of TTX-080 monotherapy…NCT04485013·Tucson, Arizona and 40 others

RecruitingA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF AlterationsThe objective of this Master Protocol is to evaluate the efficacy and safety of plixorafenib in participants with BRAF altered (BRAF V600E or BRAF fusions) locally advanced or…NCT05503797·Beverly Hills, California and 69 others

RecruitingCollection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic AnalysisBackground: \- Some genes may be associated with a greater chance of side effects during cancer treatment. These genes may also make certain treatments less effective.NCT01441089·Bethesda, Maryland

PreviousPage 14 of 45Next

Other Conditions in Maryland

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma